TELA BIO INC. - COMMON STOCK

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08 май 2023 16:30:00 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in the JMP Securities Life Sciences Conference

02 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

TELA Bio to Announce First Quarter 2023 Financial Results

27 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock

18 апр 2023 23:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock

18 апр 2023 16:01:00 Источник Nasdaq GlobeNewswire

TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023

29 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

23 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire

TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results

21 мар 2023 16:02:00 Источник Nasdaq GlobeNewswire

TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications

16 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 фев 2023 16:02:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques

21 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization

14 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

20 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds

09 янв 2023 07:00:01 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference

21 дек 2022 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 дек 2022 16:02:00 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference

21 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2022 Financial Results

09 ноя 2022 16:01:00 Источник Nasdaq GlobeNewswire

TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum

03 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 окт 2022 16:05:00 Источник Nasdaq GlobeNewswire